Kane Net Interest Income from 2010 to 2026
| KNE Stock | CAD 0.04 0.00 0.00% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter -98.6 K | Current Value -63.9 K | Quarterly Volatility 112 K |
Check Kane Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kane Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 288.1 K, Total Revenue of 2.5 M or Gross Profit of 1.1 M, as well as many indicators such as Price To Sales Ratio of 7.73, Dividend Yield of 0.0 or Days Sales Outstanding of 16.88. Kane financial statements analysis is a perfect complement when working with Kane Biotech Valuation or Volatility modules.
Kane | Net Interest Income |
The evolution of Net Interest Income for Kane Biotech provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Kane Biotech compares to historical norms and industry peers.
Latest Kane Biotech's Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Kane Biotech over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Kane Biotech's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kane Biotech's overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Kane Net Interest Income Regression Statistics
| Arithmetic Mean | (288,188) | |
| Coefficient Of Variation | (105.39) | |
| Mean Deviation | 234,233 | |
| Median | (114,226) | |
| Standard Deviation | 303,721 | |
| Sample Variance | 92.2B | |
| Range | 1.1M | |
| R-Value | (0.68) | |
| Mean Square Error | 53.5B | |
| R-Squared | 0.46 | |
| Significance | 0 | |
| Slope | (40,616) | |
| Total Sum of Squares | 1.5T |
Kane Net Interest Income History
About Kane Biotech Financial Statements
Kane Biotech investors use historical fundamental indicators, such as Kane Biotech's Net Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kane Biotech. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -486.5 K | -510.8 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kane Stock Analysis
When running Kane Biotech's price analysis, check to measure Kane Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kane Biotech is operating at the current time. Most of Kane Biotech's value examination focuses on studying past and present price action to predict the probability of Kane Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kane Biotech's price. Additionally, you may evaluate how the addition of Kane Biotech to your portfolios can decrease your overall portfolio volatility.